Fundraising FoxBain Capital Tech Opportunities — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Cardurion is a cardiovascular disease-focused company developing therapeutics, with a pipeline advanced through clinical development, trial design, regulatory affairs, and commercialization.
BiotechDigital HealthHealthtechMedical DevicesBurlington, US
Michael E. Mendelsohn(Founder and Chief Strategy Officer)in
Co-investorsBain CapitalAscenta CapitalDelos CapitalDigitalis VenturesNew Enterprise Associates (NEA)Bain Capital Life Sciences+4 more
Defense Unicorns delivers secure, vendor-lock-free software deployment solutions for the U.S.
Cloud ComputingDefense TechDeveloper ToolsGovTechColorado Springs, US
Rob Slaughter(Founder)inJeff McCoy(Founder)inAndrew Greene(Founder)inThomas Runyon(Executive Officer)
Co-investorsAnsa CapitalSapphire VenturesUncorrelated VenturesValor Equity PartnersAtlantic Vantage PointAXA Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.